Cardiotoxicity and Cardioprotection in Childhood Cancer
Population
Children diagnosed with cancer exposed to anthracycline chemotherapy (such as doxorubicin) and/or radiation
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May inform cardiotoxicity monitoring in survivors; leaves open optimal cardioprotective strategies pending prospective trials.
Structured PICO
P
Population
Children diagnosed with cancer exposed to anthracycline chemotherapy (such as doxorubicin) and/or radiation
I
Intervention
Cardioprotective strategies including dexrazoxane, less toxic anthracycline derivatives, and nutritional supplements
O
Outcome
Cardiotoxicity (persistent and progressive cardiovascular damage)
This review highlights the risk factors for cardiotoxicity in childhood cancer survivors and discusses cardioprotective strategies such as dexrazoxane.
Cite This Study
Lipshultz et al. (2014) studied this question.